Trial intelligence / Profile preview

Ammonia Inhalants for Performance During Sleep Deprivation

NCT05868798Phase 1Completed

Start
Oct 2020
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ammonia in sleep deprivation (2 arms). Primary endpoints: Epworth Sleepiness Scale at 44 hours, Simple Reaction Time at 44 hours and 5 more. Started Oct 2020; status: completed.

02

Drugs

ammonia
03

Conditions

sleep deprivation

Beyond the preview

Go deeper on NCT05868798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05868798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call